Cargando…
Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants
The coronavirus disease 2019 (COVID-19) pandemic has demonstrated a clear need for high-throughput, multiplexed and sensitive assays for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other respiratory viruses and their emerging variants. Here, we present a cost-effective...
Ejemplares similares
-
Model-directed generation of CRISPR-Cas13a guide RNAs designs artificial sequences that improve nucleic acid detection
por: Mantena, Sreekar, et al.
Publicado: (2023) -
Designing sensitive viral diagnostics with machine learning
por: Metsky, Hayden C., et al.
Publicado: (2022) -
Massively multiplexed nucleic acid detection with Cas13
por: Ackerman, Cheri M., et al.
Publicado: (2020) -
Multiplexed detection of bacterial nucleic acids using Cas13 in droplet microarrays
por: Thakku, Sri Gowtham, et al.
Publicado: (2022) -
Strengthening healthcare delivery with remote patient monitoring in the time of COVID-19
por: Mantena, Sreekar, et al.
Publicado: (2021)